{
  "questions": [
    {
      "question": "What is the main function of insulin?",
      "options": [
        "Increase blood glucose levels",
        "Lower blood glucose levels",
        "Regulate body temperature",
        "Control blood pressure"
      ],
      "correctAnswer": 2,
      "explanation": "Insulin is a hormone produced by the pancreas that facilitates the entry of glucose into cells, thus reducing blood glucose levels."
    },
    {
      "question": "What gland produces growth hormone?",
      "options": [
        "the thyroid",
        "The anterior pituitary",
        "The adrenals",
        "the pancreas"
      ],
      "correctAnswer": 2,
      "explanation": "Growth hormone (somatotropin) is produced by the anterior pituitary gland (adenohypophysis) and is essential for growth and development."
    },
    {
      "question": "What is the most common cause of hypothyroidism?",
      "options": [
        "thyroid tumor",
        "Hashimoto's thyroiditis",
        "Iodine deficiency",
        "Excess antithyroid medications"
      ],
      "correctAnswer": 2,
      "explanation": "Hashimoto's thyroiditis is an autoimmune disease that is the most common cause of hypothyroidism in iodine-sufficient countries."
    },
    {
      "question": "What hormone regulates calcium metabolism?",
      "options": [
        "insulin",
        "Parathormone (PTH)",
        "Cortisol",
        "aldosterone"
      ],
      "correctAnswer": 2,
      "explanation": "Parathormone (PTH) is produced by the parathyroid glands and is the main hormone that regulates calcium and phosphorus metabolism."
    },
    {
      "question": "What is the function of cortisol?",
      "options": [
        "Regulate glucose",
        "Respond to stress and regulate metabolism",
        "Control blood pressure",
        "Regulate sleep"
      ],
      "correctAnswer": 2,
      "explanation": "Cortisol is a steroid hormone produced by the adrenal cortex that helps the body respond to stress and regulates carbohydrate, protein, and fat metabolism."
    },
    {
      "question": "What is type 1 diabetes mellitus?",
      "options": [
        "insulin resistance",
        "Autoimmune destruction of pancreatic beta cells",
        "Glucagon deficiency",
        "Excess insulin"
      ],
      "correctAnswer": 2,
      "explanation": "Type 1 diabetes is an autoimmune disease in which the immune system destroys the beta cells of the pancreas that produce insulin."
    },
    {
      "question": "What is the hormone that regulates the sleep-wake cycle?",
      "options": [
        "melatonin",
        "Cortisol",
        "insulin",
        "Thyroxine"
      ],
      "correctAnswer": 1,
      "explanation": "Melatonin is produced by the pineal gland and regulates the circadian (sleep-wake) cycle, being secreted mainly at night."
    },
    {
      "question": "What is Cushing's syndrome?",
      "options": [
        "Cortisol deficiency",
        "Excess cortisol",
        "Aldosterone deficiency",
        "Excess insulin"
      ],
      "correctAnswer": 2,
      "explanation": "Cushing syndrome is caused by excessive levels of cortisol, either from cortisol-producing tumors or from excessive use of corticosteroids."
    },
    {
      "question": "What is the function of aldosterone?",
      "options": [
        "Regulate glucose",
        "Regulate sodium and potassium balance",
        "Control the temperature",
        "Regulate growth"
      ],
      "correctAnswer": 2,
      "explanation": "Aldosterone is a mineralocorticoid hormone that regulates sodium and potassium balance, and therefore blood pressure and fluid volume."
    },
    {
      "question": "What is acromegaly?",
      "options": [
        "Excess growth hormone in adults",
        "Growth hormone deficiency",
        "Thyroxine deficiency",
        "Excess insulin"
      ],
      "correctAnswer": 1,
      "explanation": "Acromegaly is caused by excess growth hormone in adults, usually from a tumor of the pituitary gland, which causes excessive growth of bones and soft tissues."
    },
    {
      "question": "What is the function of thyroxine (T4)?",
      "options": [
        "Regulate glucose",
        "Regulate basal metabolism",
        "Control blood pressure",
        "Regulate sleep"
      ],
      "correctAnswer": 2,
      "explanation": "Thyroxine (T4) is the main thyroid hormone that regulates basal metabolism, growth, development and function of many organs."
    },
    {
      "question": "What is goiter?",
      "options": [
        "thyroid tumor",
        "Enlarged thyroid gland",
        "Thyroid inflammation",
        "Iodine deficiency"
      ],
      "correctAnswer": 2,
      "explanation": "Goiter is an enlargement of the thyroid gland, which may be diffuse or nodular, and may be associated with normal, increased, or decreased thyroid function."
    },
    {
      "question": "What is the function of glucagon?",
      "options": [
        "Increase blood glucose",
        "Lower blood glucose",
        "Regulate blood pressure",
        "Control the temperature"
      ],
      "correctAnswer": 1,
      "explanation": "Glucagon is a hormone produced by the alpha cells of the pancreas that increases blood glucose levels by stimulating glycogenolysis and gluconeogenesis."
    },
    {
      "question": "What is diabetes insipidus?",
      "options": [
        "Excess insulin",
        "Vasopressin deficiency (ADH)",
        "Excess glucose",
        "Cortisol deficiency"
      ],
      "correctAnswer": 2,
      "explanation": "Diabetes insipidus is caused by vasopressin (antidiuretic hormone) deficiency, resulting in excessive excretion of dilute urine and intense thirst."
    },
    {
      "question": "What is the function of vasopressin (ADH)?",
      "options": [
        "Regulate water balance",
        "Regulate glucose",
        "Control blood pressure",
        "Regulate growth"
      ],
      "correctAnswer": 1,
      "explanation": "Vasopressin (antidiuretic hormone) regulates water balance in the body by controlling water reabsorption in the kidneys."
    },
    {
      "question": "What is pheochromocytoma?",
      "options": [
        "Pituitary tumor",
        "Tumor of the adrenal medulla that produces catecholamines",
        "thyroid tumor",
        "pancreas tumor"
      ],
      "correctAnswer": 2,
      "explanation": "Pheochromocytoma is a tumor of the adrenal medulla that produces excess catecholamines, causing paroxysmal hypertension and other symptoms."
    },
    {
      "question": "What is the function of testosterone?",
      "options": [
        "Regulate glucose",
        "Development of male sexual characteristics",
        "Control blood pressure",
        "Regulate sleep"
      ],
      "correctAnswer": 2,
      "explanation": "Testosterone is the primary male sex hormone that promotes the development of secondary sexual characteristics and maintains male reproductive function."
    },
    {
      "question": "What is menopause?",
      "options": [
        "Estrogen deficiency",
        "Permanent cessation of menstruation",
        "Excess progesterone",
        "Testosterone deficiency"
      ],
      "correctAnswer": 2,
      "explanation": "Menopause is the permanent cessation of menstruation due to decreased ovarian function and estrogen levels."
    },
    {
      "question": "What is the function of prolactin?",
      "options": [
        "Regulate glucose",
        "Stimulate breast milk production",
        "Control blood pressure",
        "Regulate growth"
      ],
      "correctAnswer": 2,
      "explanation": "Prolactin is a hormone produced by the pituitary gland that stimulates the production of breast milk and has other functions in reproduction."
    },
    {
      "question": "What is metabolic syndrome?",
      "options": [
        "A set of cardiovascular risk factors",
        "a single disease",
        "insulin deficiency",
        "Excess cortisol"
      ],
      "correctAnswer": 1,
      "explanation": "Metabolic syndrome is a set of risk factors including abdominal obesity, insulin resistance, dyslipidemia and hypertension, which increase the risk of cardiovascular disease and diabetes."
    },
    {
      "question": "Who coined the term acromegaly?",
      "options": [
        "Minkowski",
        "Saucerotte",
        "Pierre Marie",
        "Benda"
      ],
      "correctAnswer": 3,
      "explanation": "Pierre Marie coined the term acromegaly in 1885 to describe abnormal growth of the limbs and head, and related it to the pituitary gland."
    },
    {
      "question": "What is the main function of hormones?",
      "options": [
        "Be growth factors",
        "be chemical messengers",
        "Be structural components",
        "Being energetic molecules"
      ],
      "correctAnswer": 2,
      "explanation": "Hormones are chemical messengers produced in specific organs to act at a distance, providing chemical coordination in the body."
    },
    {
      "question": "What concept did Claude Bernard create in 1855?",
      "options": [
        "cellular homeostasis",
        "Regulation by receptors",
        "internal secretion",
        "blood circulation"
      ],
      "correctAnswer": 3,
      "explanation": "Claude Bernard created the term and concept of internal secretion, referring to substances that cells deposit in the internal environment or blood."
    },
    {
      "question": "Who demonstrated the importance of the adrenal for life?",
      "options": [
        "Thomas Addison",
        "Claude Bernard",
        "J. Müller",
        "Brown-Séquard"
      ],
      "correctAnswer": 4,
      "explanation": "Charles-Édouard Brown-Séquard began his experiments in 1856, concluding that the adrenal glands are essential for life."
    },
    {
      "question": "In which papyrus is the first mention of diabetes found?",
      "options": [
        "The Edwin Smith Papyrus",
        "The Ebers Papyrus",
        "Galen's treatise",
        "Aretaeus's manual"
      ],
      "correctAnswer": 2,
      "explanation": "The first reference to diabetes mellitus is found in the Ebers Papyrus (1550 BC), where symptoms such as polyuria are described."
    },
    {
      "question": "What is the original meaning of the word 'diabetes'?",
      "options": [
        "Honey flavor",
        "glucose in urine",
        "Excessive flow of water",
        "Uncontrollable thirst"
      ],
      "correctAnswer": 3,
      "explanation": "Aretaeus of Cappadocia gave the condition the name diabetes, which means 'siphon' in Greek, referring to the sign of exaggerated elimination of water by the kidney."
    },
    {
      "question": "Who isolated insulin in 1921?",
      "options": [
        "Banting, Best and Collip",
        "Sanger and Best",
        "Pende and Loewi",
        "Murlin and Frank"
      ],
      "correctAnswer": 1,
      "explanation": "In 1921, Banting, Best and Collip isolated insulin for the first time, applying it to patient Leonard Thompson."
    },
    {
      "question": "Where are steroid and thyroid receptors located?",
      "options": [
        "plasma membrane",
        "endoplasmic reticulum",
        "in the cell nucleus",
        "Only in cytoplasm"
      ],
      "correctAnswer": 3,
      "explanation": "Steroid and thyroid hormones, being fat-soluble, have their receptors in the nuclear membrane or cytoplasm."
    },
    {
      "question": "What is the half-life of glucocorticoids?",
      "options": [
        "few seconds",
        "few minutes",
        "Weeks",
        "Hours or up to a day"
      ],
      "correctAnswer": 4,
      "explanation": "Glucocorticoids are characterized by having a relatively long half-life, with great variability, ranging from hours to a day."
    },
    {
      "question": "Which researcher first described parathyroid?",
      "options": [
        "Sandstrom",
        "vassal",
        "Von Recklinghausen",
        "Trousseau"
      ],
      "correctAnswer": 1,
      "explanation": "Sandstrom made the first description of the parathyroid glands in 1880."
    },
    {
      "question": "What hormones circulate freely in the blood?",
      "options": [
        "Steroid hormones",
        "Thyroid hormones",
        "Aldosterone",
        "protein hormones"
      ],
      "correctAnswer": 4,
      "explanation": "Protein hormones are water-soluble and can circulate freely, although some also bind to protein transporters."
    },
    {
      "question": "What type of receptor do peptide hormones use?",
      "options": [
        "Tyrosine kinase",
        "JAK Cytokines",
        "Nuclear receptors",
        "membrane receptors"
      ],
      "correctAnswer": 4,
      "explanation": "Peptide and protein hormones are water-soluble, so they attach to receptors on the cell membrane to trigger their action."
    },
    {
      "question": "Who detected cAMP as a second messenger?",
      "options": [
        "Sutherland et al.",
        "loewi",
        "Harris",
        "Guillemin and Schally"
      ],
      "correctAnswer": 1,
      "explanation": "In 1962, Sutherland and his team detected the presence of 3',5' cyclic adenosine monophosphate (cAMP), demonstrating its function as a second messenger."
    },
    {
      "question": "Who managed to synthesize the hormone thyroxine?",
      "options": [
        "Kendall",
        "Harington",
        "Hashimoto",
        "Ashwood"
      ],
      "correctAnswer": 2,
      "explanation": "Harington determined the chemical structure of thyroxine in 1926 and synthesized it in 1927."
    },
    {
      "question": "Who conceptualized the radioimmunoanalysis technique?",
      "options": [
        "Berson and Yalow",
        "Rosalyn Yalow",
        "Guillemin",
        "Sanger"
      ],
      "correctAnswer": 1,
      "explanation": "Berson and Yalow conceptualized radioimmunoassay (RIA) in 1963, a technique of enormous use in the diagnosis of endocrine disorders."
    },
    {
      "question": "Who discovered LHRH-releasing hormone?",
      "options": [
        "Meites",
        "Selye",
        "Pincus",
        "McCann and Harris"
      ],
      "correctAnswer": 4,
      "explanation": "McCann and Harris discovered luteinizing hormone-releasing hormone (LHRH) in the 1960s."
    },
    {
      "question": "Who founded experimental endocrine physiology?",
      "options": [
        "Claude Bernard",
        "Thomas Addison",
        "J. Müller",
        "Brown-Séquard"
      ],
      "correctAnswer": 4,
      "explanation": "Charles-Édouard Brown-Séquard is recognized as the creator of experimental endocrine physiology, after his experiments with the adrenal glands."
    },
    {
      "question": "What cytokine does the adipocyte secrete?",
      "options": [
        "Interferon gamma",
        "p-53 factor",
        "Activin",
        "Necrosis factor"
      ],
      "correctAnswer": 1,
      "explanation": "The adipocyte, as an endocrine organ, secretes several factors, including cytokines such as interleukin-6 and interferon gamma."
    },
    {
      "question": "Who coined the term 'myxoedema'?",
      "options": [
        "order",
        "Graves",
        "parry",
        "kocher"
      ],
      "correctAnswer": 1,
      "explanation": "In 1878, researcher Ord coined the term myxedema to describe a clinical condition related to hypothyroidism."
    },
    {
      "question": "What is a gene that can cause cancer when mutated?",
      "options": [
        "The P21 gene",
        "The Gs gene",
        "The P53 protein",
        "The aquoporfin gene"
      ],
      "correctAnswer": 3,
      "explanation": "The P53 protein (encoded by a gene) is a crucial factor in the regulation of oncogenes and its mutations lead to various types of cancers."
    },
    {
      "question": "Which complement pathway initiates with IgG binding?",
      "options": [
        "Properdina pathway.",
        "Alternative route.",
        "Classic route.",
        "Lecithin pathway."
      ],
      "correctAnswer": 3,
      "explanation": "The classical pathway of complement activation is initiated by the binding of antibodies, specifically **IgG** or **IgM**, to the surface of the pathogen or antigen."
    },
    {
      "question": "What protein complex forms pores in the membrane?",
      "options": [
        "Complex C3b.",
        "Complex C1.",
        "Attack complex.",
        "Complex C5a."
      ],
      "correctAnswer": 3,
      "explanation": "The **Membrane Attack Complex (MAC)** is formed by the polymerization of the C9 protein, which creates pores in the target cell and causes its osmotic lysis."
    },
    {
      "question": "What immunoglobulin mediates the type I hypersensitivity reaction?",
      "options": [
        "IgG.",
        "IgA.",
        "IgM.",
        "IgE."
      ],
      "correctAnswer": 4,
      "explanation": "**Type I** hypersensitivity (allergic phenomena and anaphylaxis) is mainly mediated by antibodies of the **IgE** class, which activate mast cells."
    },
    {
      "question": "What type of cell mediates type IV hypersensitivity?",
      "options": [
        "T cells.",
        "B cells.",
        "Mast cells.",
        "Plasma cells."
      ],
      "correctAnswer": 1,
      "explanation": "**Type IV** hypersensitivity (delayed, such as contact dermatitis) is the only one of the four types mediated by **T cells** (T lymphocytes)."
    },
    {
      "question": "What disease is associated with HLA B8 and DR3?",
      "options": [
        "Addison's disease.",
        "Lupus.",
        "Thyroiditis.",
        "Sclerosis."
      ],
      "correctAnswer": 1,
      "explanation": "Certain types of **HLA** complexes, such as B8 and DR3, have a genetic predisposition to develop **Addison's Disease**, an autoimmune adrenal insufficiency."
    },
    {
      "question": "What organ is infiltrated in Hashimoto's thyroiditis?",
      "options": [
        "Pancreas.",
        "Thyroid.",
        "Adrenal capsule.",
        "Gonads."
      ],
      "correctAnswer": 2,
      "explanation": "Hashimoto's thyroiditis is an autoimmune disease of the thyroid gland, characterized by a profuse infiltration of lymphocytes and mononuclear phagocytes."
    },
    {
      "question": "What cells does insulitis destroy in type 1 diabetes?",
      "options": [
        "Beta cells.",
        "Alpha cells.",
        "acinar cells.",
        "Delta cells."
      ],
      "correctAnswer": 1,
      "explanation": "Type 1 diabetes mellitus is caused by the destruction of the **beta cells** of the islets of Langerhans by an insulitis triggered by cytotoxic T cells."
    },
    {
      "question": "What portion of the sphenoid houses the pituitary gland?",
      "options": [
        "Optical conduit.",
        "Turkish chair.",
        "Great cistern.",
        "Sphenoid sinus."
      ],
      "correctAnswer": 2,
      "explanation": "The pituitary gland is protected at the base of the skull within the sella turcica, a portion of the sphenoid bone."
    },
    {
      "question": "From which outpouching does the adenohypophysis originate?",
      "options": [
        "Rathke bag.",
        "Infundibulum.",
        "Diencephalon.",
        "Cinereous tubercle."
      ],
      "correctAnswer": 1,
      "explanation": "The anterior lobe of the pituitary (**adenohypophysis**) originates embryologically from **Rathke's pouch**, a dorsal ectodermal outpouching of the stomodeum."
    },
    {
      "question": "What are the neurohypophyseal support cells called?",
      "options": [
        "Somatotrophs.",
        "Pituicitos.",
        "Thyrotropes.",
        "Corticotrophs."
      ],
      "correctAnswer": 2,
      "explanation": "The neurohypophysis (posterior lobe) contains supporting neuroglial cells called pituicytes, which help in the secretion and transport of hormones from this gland."
    },
    {
      "question": "What cell type is 50% of the adenohypophysis?",
      "options": [
        "Corticotrophs.",
        "Lactotropes.",
        "Gonadotropes.",
        "Somatotrophs."
      ],
      "correctAnswer": 4,
      "explanation": "**Somatotroph** cells are the most numerous in the adenohypophysis, constituting **50%** of the total cells, and they are the producers of growth hormone (GH)."
    },
    {
      "question": "What pituitary cells produce POMC and ACTH?",
      "options": [
        "Thyrotropes.",
        "Lactotropes.",
        "Corticotrophs.",
        "Somatotrophs."
      ],
      "correctAnswer": 3,
      "explanation": "**Corticotrophs** are the cells of the adenohypophysis responsible for the production of **proopiomelanocortin (POMC)** and **adrenocorticotropin (ACTH)**."
    },
    {
      "question": "What hormones are produced in the supraoptic and paraventricular nuclei?",
      "options": [
        "TSH and PRL.",
        "Oxytocin and vasopressin.",
        "ACTH and GH.",
        "FSH and LH."
      ],
      "correctAnswer": 2,
      "explanation": "The magnocellular neurosecretory system, which originates in the **supraoptic** and **paraventricular** nuclei of the hypothalamus, produces the hormones **oxytocin and vasopressin** (ADH)."
    },
    {
      "question": "What is the main pituitary function of TRH?",
      "options": [
        "Inhibit GH.",
        "Stimulate TSH.",
        "Release FSH.",
        "Inhibit PRL."
      ],
      "correctAnswer": 2,
      "explanation": "**Thyrotropin Releasing Hormone (TRH)** has as its main physiological function **stimulating the secretion of TSH** (thyroid stimulating hormone) in the anterior pituitary gland."
    },
    {
      "question": "Which somatostatin analogue is used clinically?",
      "options": [
        "Octreotide.",
        "Lanreotide.",
        "Pasireotide.",
        "Somatropin."
      ],
      "correctAnswer": 1,
      "explanation": "Octreotide is a somatostatin analogue that is used clinically for the treatment of secretory endocrine tumors due to its high affinity for type 2 and 5 receptors."
    },
    {
      "question": "Which hormone is affected first in sequential hypopituitarism?",
      "options": [
        "Gonadotropins.",
        "ACTH.",
        "TSH.",
        "GH."
      ],
      "correctAnswer": 4,
      "explanation": "The loss of pituitary hormonal function in hypopituitarism occurs sequentially, with growth hormone (GH) being the first to show deficiency."
    },
    {
      "question": "What is the cause of Sheehan syndrome?",
      "options": [
        "Adenoma.",
        "Hypophysitis.",
        "Postpartum hemorrhage.",
        "Cranial trauma."
      ],
      "correctAnswer": 3,
      "explanation": "**Sheehan syndrome** is a type of hypopituitarism that is caused by necrosis of the pituitary gland after severe **postpartum uterine hemorrhage** and subsequent hypotension."
    },
    {
      "question": "What characteristic distinguishes secondary adrenal insufficiency?",
      "options": [
        "Hyperkalemia.",
        "Hyponatremia.",
        "Hyperpigmentation.",
        "There is no hyperpigmentation."
      ],
      "correctAnswer": 4,
      "explanation": "An important clinical difference between secondary adrenal insufficiency (due to ACTH deficiency) and primary adrenal insufficiency is that there is **no hyperpigmentation** of the skin."
    },
    {
      "question": "What is the main function of the thyroid gland?",
      "options": [
        "Synthesize cortisol.",
        "Release glucagon.",
        "Regulate metabolism.",
        "Synthesize ADH."
      ],
      "correctAnswer": 3,
      "explanation": "The thyroid gland is responsible for the synthesis and release of thyroid hormones (T3 and T4), which are essential to **regulate and maintain multiple metabolic processes**."
    },
    {
      "question": "What is the functional unit of the thyroid gland?",
      "options": [
        "Parenchyma.",
        "Stroma.",
        "Follicle.",
        "C cell."
      ],
      "correctAnswer": 3,
      "explanation": "The basic functional unit of the thyroid gland is the **thyroid follicle**, an oval or round structure lined by a single layer of epithelial cells (thyrocytes)."
    },
    {
      "question": "What is the characteristic skin condition of Graves' disease?",
      "options": [
        "Dry and rough skin",
        "Generalized hives",
        "Pretibial myxedema",
        "Psoriasis plaques"
      ],
      "correctAnswer": 3,
      "explanation": "Pretibial myxedema is the characteristic skin condition of Graves' disease, manifested as infiltrated and indurated plaques, often with an 'orange peel' appearance, located mainly in the pretibial region."
    },
    {
      "question": "What is the risk of malignancy in a 'hot' nodule on the scan?",
      "options": [
        "Greater than 50%",
        "Close to 20%",
        "Less than 1%",
        "Same as a 'cold' nodule"
      ],
      "correctAnswer": 3,
      "explanation": "A hyperfunctioning or 'hot' nodule on the scan, which is related to hyperthyroidism, has a very low chance of being malignant, generally less than 1%."
    },
    {
      "question": "What active mutation is linked to autonomous thyroid nodule?",
      "options": [
        "p53 gene",
        "TSH receptor",
        "BRAF oncogene",
        "BCL-2 protein"
      ],
      "correctAnswer": 2,
      "explanation": "Autonomous or toxic nodules have been associated with activating mutations of the TSH receptor and, to a lesser extent, mutations in the TSH receptor G protein alpha subunit gene."
    },
    {
      "question": "What condition does excess iodine produce in multinodular goiter?",
      "options": [
        "Kussmaul phenomenon",
        "Hashimoto's syndrome",
        "Wolff-Chaikoff effect",
        "Jod-Basedow phenomenon"
      ],
      "correctAnswer": 4,
      "explanation": "The Jod-Basedow phenomenon is thyrotoxicosis that occurs in patients with multinodular goiter (with functional autonomy) due to exposure to excessive concentrations of inorganic iodine, such as in contrast media or amiodarone."
    },
    {
      "question": "What characterizes apathetic hyperthyroidism in the elderly?",
      "options": [
        "Intense tremor",
        "Few demonstrations",
        "Multinodular goiter",
        "memory loss"
      ],
      "correctAnswer": 2,
      "explanation": "Apathetic hyperthyroidism is a condition seen in elderly patients, where thyrotoxicosis presents with few or limited clinical manifestations to one organ (e.g. atrial fibrillation, chronic diarrhea), and the patient appears passive."
    },
    {
      "question": "Which laboratory profile suggests central hyperthyroidism?",
      "options": [
        "Suppressed TSH with low T3/T4",
        "High T3/T4 with suppressed TSH",
        "Normal T3/T4 with low TSH",
        "High T3/T4 with normal or high TSH"
      ],
      "correctAnswer": 4,
      "explanation": "Central hyperthyroidism, caused by TSHoma, is characterized by elevated concentrations of T3 and T4, but with TSH that is normal or inappropriately elevated due to autonomous production by a pituitary tumor."
    },
    {
      "question": "What is used to distinguish thyroiditis from hyperthyroidism?",
      "options": [
        "Creatinine levels",
        "The lipid profile",
        "Thyroid flow on ultrasound",
        "stress test"
      ],
      "correctAnswer": 3,
      "explanation": "Thyroid ultrasound, specifically measurement of thyroid flow (Doppler), is useful for differential diagnosis: hyperthyroidism (hyperfunction) shows increased flow, while thyroiditis (destruction) shows decreased flow."
    },
    {
      "question": "Which serious adverse effect of FAAT is most common in the first two months?",
      "options": [
        "Mild hives",
        "Transient cholestasis",
        "Arthralgias and arthritis",
        "Agranulocytosis"
      ],
      "correctAnswer": 4,
      "explanation": "Agranulocytosis is the most serious adverse effect of antithyroid drugs (FAAT). Although idiosyncratic, in about 70% of cases it occurs during the first two months of treatment."
    },
    {
      "question": "Which painful gland suggests subacute thyroiditis?",
      "options": [
        "Little palpable gland",
        "Enlarged and painful thyroid",
        "Diffuse and soft goiter",
        "Multiple nodules without pain"
      ],
      "correctAnswer": 2,
      "explanation": "An enlarged, nodular, and very painful thyroid gland, accompanied by thyrotoxicosis and systemic symptoms (such as fever), typically suggests subacute or De Quervain's thyroiditis."
    },
    {
      "question": "What substance inhibits the peripheral conversion of T4 to T3?",
      "options": [
        "Lugol",
        "Methimazole",
        "Propylthiouracil",
        "lithium carbonate"
      ],
      "correctAnswer": 3,
      "explanation": "Propylthiouracil (PTU), in addition to its main antithyroid mechanism of action, has the property of inhibiting the peripheral deiodination of T4 (thyroxine) to the more active hormone, T3 (triiodothyronine)."
    },
    {
      "question": "What is the hormone produced by C or parafollicular cells?",
      "options": [
        "Calcitonin",
        "Thyroxine (T4)",
        "Thyroglobulin",
        "parathyroid hormone"
      ],
      "correctAnswer": 1,
      "explanation": "The C or parafollicular cells of the thyroid gland are neuroendocrine cells responsible for the production and release of the hormone calcitonin, and are the origin of medullary thyroid carcinoma."
    },
    {
      "question": "What is the main antigen in Graves' disease?",
      "options": [
        "parathyroid hormone receptor",
        "Antiperoxidase antibody",
        "TSH receptor",
        "Thyroglobulin"
      ],
      "correctAnswer": 3,
      "explanation": "The antigen responsible for the immune response in Graves' disease is the TSH receptor. Antibodies that stimulate this receptor cause hyperthyroidism by hyperstimulating thyroid cells."
    },
    {
      "question": "What study is contraindicated in pregnancy with thyrotoxicosis?",
      "options": [
        "Thyroid ultrasound",
        "Thyroid profile",
        "Thyroid scan",
        "Anti-TSH antibodies"
      ],
      "correctAnswer": 3,
      "explanation": "A thyroid scan, which uses radioactive iodine, is contraindicated in pregnant women due to the risk of affecting the fetal thyroid."
    },
    {
      "question": "What causes thyrotoxicosis by release of stored hormones?",
      "options": [
        "TSH-producing tumor",
        "Amiodarone intake",
        "Toxic multinodular goiter",
        "glandular destruction"
      ],
      "correctAnswer": 4,
      "explanation": "Thyrotoxicosis without hyperthyroidism (as in thyroiditis) is caused by destruction of the gland, leading to the release of thyroid hormones that were previously synthesized and stored in the colloid."
    },
    {
      "question": "Which ultrasound feature suggests high risk of malignancy?",
      "options": [
        "Shape taller than wide",
        "External vascularity",
        "Size less than 5 millimeters",
        "internal cysts"
      ],
      "correctAnswer": 1,
      "explanation": "Ultrasound features of a nodule that are associated with increased risk of malignancy include hypoechogenicity, irregular borders, microcalcifications, and 'taller than wide' shape."
    },
    {
      "question": "How is thyroglobulin in factitious thyrotoxicosis?",
      "options": [
        "Very high",
        "Normal",
        "diminished",
        "Not detectable"
      ],
      "correctAnswer": 3,
      "explanation": "In factitious thyrotoxicosis, caused by the ingestion of exogenous thyroid hormones, the thyroid gland is inhibited. This results in decreased or inhibited production of thyroglobulin and low uptake of radioactive iodine."
    },
    {
      "question": "What is the most common cause of subacute thyroiditis?",
      "options": [
        "Viral or post-viral infection",
        "Bacterial infection",
        "Radiation exposure",
        "Immunomodulatory drugs"
      ],
      "correctAnswer": 1,
      "explanation": "Subacute thyroiditis (granulomatous or De Quervain's) is usually caused by a viral infection or a postviral inflammatory reaction in a genetically susceptible population."
    },
    {
      "question": "What phenomenon is the acute suspension of synthesis by inorganic iodine?",
      "options": [
        "Jod-Basedow Effect",
        "Koch phenomenon",
        "Reuter syndrome",
        "Wolff-Chaikoff effect"
      ],
      "correctAnswer": 4,
      "explanation": "The Wolff-Chaikoff phenomenon describes how high concentrations of inorganic iodine in the thyroid produce an acute suspension in both the synthesis and release of thyroid hormones."
    },
    {
      "question": "What is a risk factor for postpartum thyroiditis?",
      "options": [
        "Iodine deficiency",
        "extreme obesity",
        "Previous antithyroid antibodies",
        "Age over 45 years"
      ],
      "correctAnswer": 3,
      "explanation": "The existence of antithyroid antibodies (such as antiperoxidase antibodies) before pregnancy is a known risk factor for developing postpartum thyroiditis, which has an autoimmune origin."
    },
    {
      "question": "What is the useful protein to follow differentiated thyroid cancer?",
      "options": [
        "Albumin",
        "TSH",
        "Calcitonin",
        "Thyroglobulin"
      ],
      "correctAnswer": 4,
      "explanation": "Thyroglobulin is a protein synthesized exclusively by thyroid cells. Its determination is essential in the follow-up of differentiated thyroid cancer to identify residual or recurrent thyroid tissue after surgery."
    },
    {
      "question": "What is the only curative treatment for Medullary Thyroid Carcinoma?",
      "options": [
        "Radioactive iodine therapy",
        "combination chemotherapy",
        "Tyrosine kinase inhibitors",
        "Radical neck surgery"
      ],
      "correctAnswer": 4,
      "explanation": "Surgery is the only treatment that offers a chance of complete cure for Medullary Thyroid Carcinoma, while the other options are usually adjuvant or palliative."
    },
    {
      "question": "Which classification of Medullary Carcinoma involves metastases outside the neck?",
      "options": [
        "Advanced disease",
        "Regional disease",
        "Localized disease",
        "Recurrent illness"
      ],
      "correctAnswer": 1,
      "explanation": "Advanced disease is defined by the existence of distant metastases, indicating that surgical cure is very unlikely."
    },
    {
      "question": "What is the normal serum calcitonin level in healthy adults?",
      "options": [
        "Less than 10 pg/mL",
        "Greater than 100 pg/mL",
        "Greater than 500 pg/mL",
        "Between 10 and 50 pg/mL"
      ],
      "correctAnswer": 1,
      "explanation": "Serum calcitonin concentrations less than 10 pg/mL are considered within the normal range, this being a tumor marker for Medullary Carcinoma."
    },
    {
      "question": "What is the ten-year survival if the tumor is limited to the thyroid?",
      "options": [
        "Approximately 53%",
        "Approximately 75%",
        "Approximately 95%",
        "Approximately 40%"
      ],
      "correctAnswer": 3,
      "explanation": "Patients whose Medullary Thyroid Carcinoma is limited to the gland have the best prognosis, with a 10-year survival estimated at 95%."
    },
    {
      "question": "Which tyrosine kinase inhibitor drug was approved for advanced treatment?",
      "options": [
        "Sorafenib",
        "Vandetanib",
        "Sunitinib",
        "Imatinib"
      ],
      "correctAnswer": 2,
      "explanation": "The FDA approved the use of Vandetanib, a tyrosine kinase inhibitor, for the treatment of patients with advanced Medullary Thyroid Carcinoma."
    },
    {
      "question": "What percentage of circulating calcium corresponds to the ionized form?",
      "options": [
        "Approximately 50%",
        "Approximately 25%",
        "Approximately 75%",
        "Approximately 90%"
      ],
      "correctAnswer": 1,
      "explanation": "Ionized calcium is the biologically active form, and represents about 50% of the total calcium circulating in the bloodstream."
    },
    {
      "question": "What total serum calcium level defines Hypocalcemia?",
      "options": [
        "Below 8.5 mg/dL",
        "Greater than 10.5 mg/dL",
        "Below 7.5 mg/dL",
        "Between 8.5 and 10.5 mg/dL"
      ],
      "correctAnswer": 1,
      "explanation": "Hypocalcemia is defined as a concentration of total blood calcium below 8.5 mg/dL, or ionic calcium below 2.1 mM."
    },
    {
      "question": "What hormones mainly regulate the intestinal absorption of Calcium and Phosphorus?",
      "options": [
        "Insulin and glucagon",
        "PTH and calcitriol",
        "Thyroxine and cortisol",
        "Calcitonin and estrogen"
      ],
      "correctAnswer": 2,
      "explanation": "Parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D (calcitriol) are the main hormonal regulators of intestinal absorption and homeostasis of Calcium and Phosphorus."
    },
    {
      "question": "Approximately how much calcium is stored in the human skeleton?",
      "options": [
        "Approximately 1 kilogram",
        "Approximately 500 grams",
        "Approximately 100 grams",
        "Approximately 2 kilograms"
      ],
      "correctAnswer": 1,
      "explanation": "Bones act as the main reservoir of calcium, storing around 1 kilogram of this mineral in the human body."
    },
    {
      "question": "What percentage of the skeleton comprises cortical or compact bone?",
      "options": [
        "Approximately 10%",
        "Approximately 25%",
        "Approximately 50%",
        "Approximately 75%"
      ],
      "correctAnswer": 4,
      "explanation": "Cortical bone or compact bone tissue constitutes the external part of the bones and comprises approximately 75% of the total skeleton."
    },
    {
      "question": "What cell has as its main function the synthesis of organic bone matrix?",
      "options": [
        "Osteoclast",
        "Osteocyte",
        "Osteoblast",
        "Lining cell"
      ],
      "correctAnswer": 3,
      "explanation": "The osteoblast is the bone-forming cell, responsible for the synthesis and secretion of the organic bone matrix, known as osteoid."
    },
    {
      "question": "Which bone cell is the most abundant in mature tissue?",
      "options": [
        "mature osteocyte",
        "activated osteoclast",
        "Lining cell",
        "Inactive osteoblast"
      ],
      "correctAnswer": 1,
      "explanation": "The osteocyte, which is an osteoblast that has become trapped in the mineralized osteoid, is the most numerous cell in mature bone, with 90 to 95% of the total."
    },
    {
      "question": "How long does the resorption phase last in the bone remodeling cycle?",
      "options": [
        "Approximately 3 weeks",
        "About 1 week",
        "Approximately 3 months",
        "Approximately 6 months"
      ],
      "correctAnswer": 1,
      "explanation": "The bone resorption phase, carried out by osteoclasts to remove old or damaged bone, lasts approximately 3 weeks."
    },
    {
      "question": "Which of these is not a target tissue for decarboxylated osteocalcin?",
      "options": [
        "muscle tissue",
        "Pancreas",
        "Testicle",
        "adipose tissue"
      ],
      "correctAnswer": 1,
      "explanation": "The decarboxylated form of osteocalcin acts as a hormone, influencing the pancreas, testicle and adipose tissue, but not directly on muscle tissue."
    },
    {
      "question": "What is the main stimulus for the secretion of Parathyroid hormone (PTH)?",
      "options": [
        "High phosphorus levels",
        "Low calcium concentration",
        "High calcium concentration",
        "High levels of calcitriol"
      ],
      "correctAnswer": 2,
      "explanation": "The main factor that stimulates parathyroid cells to secrete PTH is a low concentration of calcium in the blood (hypocalcemia), which is detected by the calcium sensing receptor (CaSR)."
    },
    {
      "question": "How are PTH levels found in primary hypoparathyroidism?",
      "options": [
        "Elevated or high",
        "Normal sometimes",
        "Slightly high",
        "Undetectable or low"
      ],
      "correctAnswer": 4,
      "explanation": "In primary hypoparathyroidism, the parathyroid gland does not function properly, so Parathyroid hormone (PTH) levels are low or undetectable."
    },
    {
      "question": "What is the microdeletion associated with DiGeorge Syndrome?",
      "options": [
        "2p25.3 deletion",
        "22q11.2 microdeletion",
        "6p24.2 deletion",
        "Xq27.1 microdeletion"
      ],
      "correctAnswer": 2,
      "explanation": "DiGeorge Syndrome is characterized by microdeletions in the 22q11.2 chromosome region, resulting in parathyroid and thymic agenesis or hypoplasia."
    },
    {
      "question": "At what age does hyperparathyroidism associated with MEN2A usually appear?",
      "options": [
        "In early childhood",
        "In adulthood",
        "in adolescence",
        "In the neonatal period"
      ],
      "correctAnswer": 2,
      "explanation": "In the context of Multiple Endocrine Neoplasia type 2A (MEN2A), hyperparathyroidism generally occurs when the patient has reached adulthood."
    },
    {
      "question": "In which gene are mutations related to Pseudohypoparathyroidism type 1a found?",
      "options": [
        "RET gene",
        "GCM2 gene",
        "GNAS gene",
        "PTH gene"
      ],
      "correctAnswer": 3,
      "explanation": "Pseudohypoparathyroidism type 1a is caused by mutations in the GNAS gene, which encodes the Gs alpha subunit and is related to resistance to the action of PTH."
    },
    {
      "question": "What enzyme generates the active form of Vitamin D (Calcitriol)?",
      "options": [
        "CYP24",
        "24-hydroxylase",
        "Alkaline phosphatase",
        "1alpha-hydroxylase"
      ],
      "correctAnswer": 4,
      "explanation": "The enzyme 1 alpha-hydroxylase (or CYP1 alpha), located in the proximal tubules of the kidney, is responsible for the hydroxylation that produces calcitriol, the most active form of Vitamin D."
    },
    {
      "question": "What is the most common cause of primary hyperparathyroidism?",
      "options": [
        "Parathyroid carcinoma",
        "Four gland hyperplasia",
        "A parathyroid adenoma",
        "Multiple endocrine neoplasia"
      ],
      "correctAnswer": 3,
      "explanation": "Adenoma is the most common cause of primary hyperparathyroidism, accounting for 80 to 85% of all cases. In contrast, hyperplasia of all four parathyroid glands occurs in 10 to 15% of cases."
    },
    {
      "question": "What is the most common clinical presentation of HPT1 today?",
      "options": [
        "Osteitis fibrosa cystica",
        "Asymptomatic hypercalcemia",
        "Recurrent pancreatitis",
        "Neuromuscular symptoms"
      ],
      "correctAnswer": 2,
      "explanation": "Due to earlier diagnosis, the most common presentation of primary hyperparathyroidism is asymptomatic hypercalcemia, where patients have no specific symptoms or obvious target organ damage."
    },
    {
      "question": "What is the classic skeletal manifestation of HPT1?",
      "options": [
        "Osteitis fibrosa cystica",
        "Minor vertebral fractures",
        "Decrease in total BMD",
        "Increased bone density"
      ],
      "correctAnswer": 1,
      "explanation": "Osteitis fibrosa cystica is the classic skeletal manifestation of primary hyperparathyroidism, characterized by bone pain and specific radiological findings, although it is only observed in 5% of patients."
    },
    {
      "question": "What is the most common complication of primary hyperparathyroidism?",
      "options": [
        "Brown bone tumors",
        "Severe high blood pressure",
        "Chronic kidney disease",
        "Presence of nephrolithiasis"
      ],
      "correctAnswer": 4,
      "explanation": "Nephrolithiasis, or kidney stone formation, remains the most common complication of primary hyperparathyroidism, occurring in 15 to 20% of cases due to hypercalciuria."
    },
    {
      "question": "What is the most consistent cardiovascular finding in HPT1?",
      "options": [
        "Left ventricular hypertrophy",
        "Systemic atherosclerosis",
        "Diastolic decrease",
        "Serious cardiac arrhythmias"
      ],
      "correctAnswer": 1,
      "explanation": "Left ventricular hypertrophy (LVH) is the most consistent cardiovascular finding in primary hyperparathyroidism, and is considered a strong indicator of cardiovascular morbidity and mortality."
    },
    {
      "question": "Assays of which generation of PTH detect only PTH 1-84 and N-terminus?",
      "options": [
        "First generation, RIA",
        "Second generation, intact",
        "Third generation, bioactive",
        "Fourth generation, peptides"
      ],
      "correctAnswer": 3,
      "explanation": "Third generation assays, or bioactive PTH, are distinguished because the detection antibody is directed against the first 4 or 5 amino acids of the molecule, thus detecting only PTH 1-84 and the N-terminal PTH, considered biologically more active."
    },
    {
      "question": "What tumor suppressor gene is associated with Multiple Endocrine Neoplasia type 1?",
      "options": [
        "Cyclin D1 gene",
        "RET gene",
        "The CCND1 oncogene",
        "MEN1 gene (Menina)"
      ],
      "correctAnswer": 4,
      "explanation": "The MEN1 gene is a tumor suppressor gene that encodes the menin protein. Germline mutations of this gene result in Multiple Endocrine Neoplasia type 1 (MEN1), a syndrome that causes hyperparathyroidism."
    },
    {
      "question": "In HPT1, in which places does the decrease in Bone Mineral Density prevail?",
      "options": [
        "In the cortical bone",
        "in the spine",
        "At the proximal hip",
        "In the distal femur"
      ],
      "correctAnswer": 1,
      "explanation": "Densitometry in patients with primary hyperparathyroidism shows a decrease in Bone Mineral Density (BMD) in sites where cortical bone prevails, such as the distal third of the forearm."
    },
    {
      "question": "What is the truncated PTH fragment that has an indirect hypocalcemic effect?",
      "options": [
        "The PTH 1-84 fragment",
        "The PTH 7-84 fragment",
        "The N-terminal PTH",
        "Fragments 58-69"
      ],
      "correctAnswer": 2,
      "explanation": "The PTH 7-84 fragment is a PTH truncated in the N-terminal portion that, when interacting with the C-PTH receptor, seems to have an important effect on the regulation of bone resorption and could have an indirect hypocalcemic effect."
    },
    {
      "question": "What effect do glucocorticoids have on glucose metabolism?",
      "options": [
        "They inhibit proteolysis",
        "They decrease glycogenesis",
        "Increase liver glucose",
        "They reduce resistance"
      ],
      "correctAnswer": 3,
      "explanation": "Cortisol, a glucocorticoid, increases hepatic glucose production. It achieves this by stimulating gluconeogenesis and proteolysis, releasing substrates (amino acids) for glucose synthesis."
    },
    {
      "question": "What effect does excess glucocorticoids have on fibroblasts?",
      "options": [
        "Inhibits collagen synthesis",
        "Increases your synthesis",
        "Causes interstitial fibrosis",
        "Produces tissue hypertrophy"
      ],
      "correctAnswer": 1,
      "explanation": "In connective tissue, glucocorticoids inhibit RNA and protein synthesis in fibroblasts. This causes thinning of the subcutaneous tissue and delayed healing, which explains the ecchymoses and stretch marks in Cushing's syndrome."
    },
    {
      "question": "What is the typical skin finding of Cushing's syndrome?",
      "options": [
        "purple stretch marks",
        "Very thick skin",
        "Hyperpigmentation",
        "Painless dorsal hump"
      ],
      "correctAnswer": 1,
      "explanation": "Violaceous (purple) stretch marks on the abdomen, and sometimes on the breasts and extremities, are a characteristic manifestation of Cushing's syndrome, the result of thinning of the connective tissue due to excess cortisol."
    },
    {
      "question": "What is the most common cause of endogenous Cushing's syndrome?",
      "options": [
        "Cushing's disease",
        "Adrenal adenoma",
        "Adrenal carcinoma",
        "Micronodular dysplasia"
      ],
      "correctAnswer": 1,
      "explanation": "The most common cause of endogenous Cushing's syndrome is Cushing's disease, which is a tumor of the pituitary gland that produces ACTH, the hormone that stimulates the production of cortisol by the adrenal glands."
    },
    {
      "question": "What dynamic test evaluates the complete integrity of the hypothalamic-pituitary-adrenal axis?",
      "options": [
        "Serum cortisol measurement",
        "ACTH stimulation",
        "Hypoglycemia test",
        "Suppression with dexamethasone"
      ],
      "correctAnswer": 3,
      "explanation": "The insulin-induced hypoglycemia test is the one that measures the complete integrity of the hypothalamic-pituitary-adrenal axis, since hypoglycemia acts as a source of stress, increasing the secretion of CRH, ACTH and, therefore, cortisol."
    },
    {
      "question": "What is the typical shape of the adrenal glands?",
      "options": [
        "Rounded and smooth",
        "Pyramid and posteromedial",
        "Ovoid and anterolateral",
        "Lobed and flat"
      ],
      "correctAnswer": 2,
      "explanation": "The adrenal glands (or suprarenals) have a pyramidal shape and their position is posteromedial with respect to the kidneys. Each one weighs approximately 4 grams on average."
    },
    {
      "question": "What stimulates renin release in the RAA system?",
      "options": [
        "Increased pressure",
        "Decreased salt",
        "Increased serum potassium",
        "parasympathetic stimulation"
      ],
      "correctAnswer": 2,
      "explanation": "The main factors that stimulate renin are decreased blood pressure, upright position, and salt depletion (low-salt diet), since renin is released in response to decreased renal artery pressure."
    },
    {
      "question": "What is the primary stimulus for aldosterone release in healthy subjects?",
      "options": [
        "Angiotensin II and potassium",
        "ACTH stimulation",
        "increased sodium",
        "Vasopressin and cortisol"
      ],
      "correctAnswer": 1,
      "explanation": "In healthy subjects, angiotensin II (produced by the RAA system) and increases in serum potassium (from 3.5 mEq/L) are the primary and most potent stimuli for the release of aldosterone through the zona glomerulosa."
    },
    {
      "question": "What is the most common cause of high blood pressure of adrenal origin?",
      "options": [
        "Bilateral pheochromocytoma",
        "Primary hyperaldosteronism",
        "Mild Cushing's syndrome",
        "Carcinoma of the cortex"
      ],
      "correctAnswer": 2,
      "explanation": "Primary hyperaldosteronism (PAH) is the most common cause of high blood pressure originating in the adrenal glands, and has been found to be responsible for more than 10% of patients with moderate to severe hypertension."
    },
    {
      "question": "What is the most common cause of primary hyperaldosteronism today?",
      "options": [
        "Bilateral adrenal hyperplasia",
        "Solitary aldosteronoma",
        "suppressible aldosteronism",
        "Renin-secreting tumor"
      ],
      "correctAnswer": 1,
      "explanation": "Although historically aldosteronoma was considered the main cause, recent studies indicate that bilateral adrenal hyperplasia is responsible in about 60% of cases of primary hyperaldosteronism."
    },
    {
      "question": "What aldosterone/renin ratio value suggests primary hyperaldosteronism?",
      "options": [
        "Relationship under twenty",
        "Ratio around ten",
        "Ratio equal to fifteen",
        "Relationship greater than thirty"
      ],
      "correctAnswer": 4,
      "explanation": "In patients with primary hyperaldosteronism, the aldosterone/renin ratio is generally greater than 30 (using conventional units of ng/dL for aldosterone and ng/mL/h for plasma renin activity), while in essential arterial hypertension it is less than 20."
    },
    {
      "question": "What is the treatment of choice for aldosteronism suppressible with glucocorticoids?",
      "options": [
        "Spironolactone and amiloride",
        "Loop and potassium diuretics",
        "daily oral dexamethasone",
        "Renin blockers"
      ],
      "correctAnswer": 3,
      "explanation": "Glucocorticoid-suppressible aldosteronism is a form of primary hyperaldosteronism where aldosterone secretion is regulated by ACTH and can be suppressed by the administration of glucocorticoids. Therefore, the management of choice is with dexamethasone."
    },
    {
      "question": "What genetic disorder is characterized by increased sodium channel activity in the distal renal tubule?",
      "options": [
        "Bartter syndrome",
        "Adrenal hyperplasia",
        "Aldosterone deficiency",
        "Liddle syndrome"
      ],
      "correctAnswer": 4,
      "explanation": "Liddle Syndrome is an autosomal dominant genetic disorder characterized by an increase in the activity of the sodium channels of the distal renal tubular epithelium, leading to increased sodium reabsorption and arterial hypertension, similar to hyperaldosteronism, but with normal aldosterone."
    },
    {
      "question": "Which molecule is potently inhibited by glycyrrhetinic acid, a component of licorice?",
      "options": [
        "Renin",
        "Aldosterone synthetase",
        "11β-hydroxysteroid dehydrogenase 2",
        "Angiotensin converting enzyme"
      ],
      "correctAnswer": 3,
      "explanation": "Glycyrrhetinic acid, derived from licorice, is a potent inhibitor of the enzyme 11β-hydroxysteroid dehydrogenase 2. This prevents the conversion of cortisol to cortisone, causing excess mineralocorticoids and sodium retention."
    },
    {
      "question": "What is the most common congenital cause of mineralocorticoid deficiency?",
      "options": [
        "18-hydroxylase defect",
        "21-hydroxylase deficiency",
        "Lipoid adrenal hypoplasia",
        "3β-OH-dehydrogenase deficiency"
      ],
      "correctAnswer": 2,
      "explanation": "21-hydroxylase deficiency is the most common cause of congenital adrenal hyperplasia, occurring in 1 in every 10,000 live births. The classic form presents with increased natriuresis due to the lack of aldosterone production."
    },
    {
      "question": "In hyporeninemic hypoaldosteronism, what is the most common underlying cause?",
      "options": [
        "Addison's disease",
        "Congestive heart failure",
        "diabetic nephropathy",
        "Turner syndrome"
      ],
      "correctAnswer": 3,
      "explanation": "Hyporeninemic hypoaldosteronism is mainly seen in elderly people, with diabetic nephropathy being the most common cause. It is due to damage to the juxtaglomerular apparatus, which decreases renin production."
    },
    {
      "question": "What part of the adrenal gland corresponds to 10% of its total weight in adults?",
      "options": [
        "reticular cortex",
        "fasciculated cortex",
        "glomerular zone",
        "Adrenal medulla"
      ],
      "correctAnswer": 4,
      "explanation": "In the adult, the adrenal medulla represents approximately 10% of the total weight of the gland. The medulla is the main site of synthesis and secretion of catecholamines."
    },
    {
      "question": "Which artery does NOT supply the adrenal gland?",
      "options": [
        "Upper adrenal",
        "Median adrenal",
        "Lower adrenal",
        "mesenteric artery"
      ],
      "correctAnswer": 4,
      "explanation": "The arterial flow of the adrenal gland is ensured by the superior adrenal (branch of the superior phrenic), middle adrenal (branch of the aorta) and inferior adrenal (branch of the renal artery or aorta) arteries. The mesenteric artery is not a direct source."
    },
    {
      "question": "What enzyme converts norepinephrine to adrenaline in the adrenal medulla?",
      "options": [
        "Phenylethanolamine-N-methyltransferase",
        "Dopa decarboxylase",
        "Tyrosine hydroxylase",
        "Dopamine β-hydroxylase"
      ],
      "correctAnswer": 1,
      "explanation": "The enzyme phenylethanolamine-N-methyltransferase (PNMT) converts norepinephrine (NA) to adrenaline (A). This enzyme requires the presence of cortisol, abundant in the cortico-medullary junction."
    },
    {
      "question": "Which catecholamine is secreted in the greatest proportion (70%) by the adrenal medulla when stressed?",
      "options": [
        "Norepinephrine",
        "Dopamine",
        "Serotonin",
        "Adrenalin"
      ],
      "correctAnswer": 4,
      "explanation": "In response to a stressful situation, the cells of the adrenal medulla release catecholamines into the circulation, mainly adrenaline and norepinephrine, in an approximate ratio of 70% to 30% respectively."
    },
    {
      "question": "Which of the following is an end product of dopamine catabolism?",
      "options": [
        "vanilmandelic acid",
        "Normetanephrines",
        "homovanillic acid",
        "Metanephrines"
      ],
      "correctAnswer": 3,
      "explanation": "The catabolism of adrenaline and norepinephrine produces metanephrines and 4-hydroxy-3-methoxymandelic acid (VMA). However, homovanillic acid (HVA) is the end product of the metabolic degradation of dopamine."
    },
    {
      "question": "What is the main effect of activation of β1 adrenergic receptors on the heart?",
      "options": [
        "Positive inotropic effect",
        "Vasoconstriction",
        "Renal vasodilation",
        "Renin inhibition"
      ],
      "correctAnswer": 1,
      "explanation": "Activation of β1 receptors in the cardiomyocyte causes a positive inotropic effect (increase in contraction force) that is more intense than that produced by stimulation of α1 receptors."
    },
    {
      "question": "How does the WHO classify chromaffin cell tumors arising from the adrenal medulla?",
      "options": [
        "Glomerulocytoma",
        "Paraganglioma",
        "Chemodectomy",
        "Pheochromocytoma"
      ],
      "correctAnswer": 4,
      "explanation": "The most recent WHO classification uses the term pheochromocytoma exclusively for tumors arising from the adrenal medulla and the term extra-adrenal paraganglioma for similar tumors arising from other sites."
    },
    {
      "question": "What is the gold standard for the biochemical diagnosis of pheochromocytoma?",
      "options": [
        "Fractionated metanephrines in urine",
        "Measurement of cortisol in saliva",
        "Plasma renin activity",
        "Metanephrines fractionated in plasma and urine"
      ],
      "correctAnswer": 4,
      "explanation": "Measurement of fractionated metanephrines in plasma and urine, or both, represents the gold standard for the diagnosis of pheochromocytoma and paraganglioma."
    },
    {
      "question": "Which of the following drugs can give a false positive result in metanephrine measurements?",
      "options": [
        "Furosemide",
        "Spironolactone",
        "Insulin",
        "Acetaminophen"
      ],
      "correctAnswer": 4,
      "explanation": "A large number of drugs can interfere with metanephrine measurements, giving a false positive result. Some of these medications include acetaminophen, labetalol, sotalol, and tricyclic antidepressants, among others."
    },
    {
      "question": "What is the liporegulatory hormone recognized for maintaining normal intracellular lipid homeostasis?",
      "options": [
        "Insulin",
        "Adiponectin",
        "Leptin",
        "Resistin"
      ],
      "correctAnswer": 3,
      "explanation": "Novel concepts postulate leptin as the main liporegulatory hormone, maintaining normal intracellular lipid homeostasis, analogous to insulin glucoregulation. Leptin decreases intracellular lipids and increases insulin sensitivity."
    },
    {
      "question": "Adiponectin is inversely related to the concentration of what type of fat?",
      "options": [
        "Subcutaneous fat",
        "Pelvic fat",
        "visceral fat",
        "intramuscular fat"
      ],
      "correctAnswer": 3,
      "explanation": "Serum adiponectin concentrations are inversely related to the amount of visceral fat; The greater the accumulation of visceral fat, the less circulating adiponectin. Hypoadiponectinemia is a risk factor for insulin resistance."
    },
    {
      "question": "What molecule is inhibited by leptin to decrease the synthesis of triglycerides and fatty acids?",
      "options": [
        "Acyl CoA oxidase",
        "Carnitine-palmitoyl transferase 1",
        "Acetyl CoA carboxylase",
        "Adenylate cyclase"
      ],
      "correctAnswer": 3,
      "explanation": "Leptin increases the activity of AMP kinase (AMPK), whose action is to block the formation of Acetyl CoA carboxylase (ACC). Blocking ACC inhibits the synthesis of malonyl CoA, which is the first step in the formation of triglycerides and fatty acids (antisteatotic effect)."
    },
    {
      "question": "What protein binds to and activates the insulin receptor, having a positive effect on glucose uptake?",
      "options": [
        "TNFα",
        "Resistin",
        "Visfatin",
        "Adiponectin"
      ],
      "correctAnswer": 3,
      "explanation": "Visfatin has a positive effect on insulin-mediated glucose uptake by directly binding and activating the insulin receptor. Although its binding site is different from that of insulin, it does not promote insulin resistance."
    },
    {
      "question": "Which kinase inhibits insulin signaling through serine phosphorylation of IRS-1 in obesity?",
      "options": [
        "AMPK",
        "c-Jun NH2-terminal kinase (JNK)",
        "Tyrosine hydroxylase",
        "MAP Kinase"
      ],
      "correctAnswer": 2,
      "explanation": "Activation of inflammatory kinases such as c-Jun NH2-terminal kinase (JNK) and IKK contribute to the inhibition of insulin signaling. JNK, in particular, causes inhibitory phosphorylation of insulin receptor substrate 1 (IRS-1) on serine residues."
    },
    {
      "question": "What is an immediate surgical indication for an adrenal incidentaloma?",
      "options": [
        "Lesions less than 4 cm",
        "Non-functioning adenomas",
        "Lesions larger than 6 cm",
        "Attenuation less than 5 UH"
      ],
      "correctAnswer": 3,
      "explanation": "The treatment of some incidentalomas is surgical. Indications include all functioning adenomas and all incidentalomas larger than 6 cm, as well as those smaller than 6 cm with an attenuation in Hounsfield units greater than 10."
    },
    {
      "question": "What is the most common monogenic dyslipidemia?",
      "options": [
        "Mixed hyperlipidemia",
        "Familial hypertriglyceridemia",
        "Dysbetalipoproteinemia",
        "Familial hypercholesterolemia"
      ],
      "correctAnswer": 4,
      "explanation": "Familial hypercholesterolemia has an estimated prevalence of 1 in 500 and is associated with the highest risk of atherosclerosis."
    },
    {
      "question": "What apoprotein is present in atherogenic lipoproteins?",
      "options": [
        "Apoprotein C-II",
        "Apoprotein B",
        "Apoprotein E",
        "Apoprotein A-I"
      ],
      "correctAnswer": 2,
      "explanation": "Atherogenic lipoproteins (such as VLDL 3, remnants, IDL and LDL) have in common the presence of apoprotein B."
    },
    {
      "question": "Which lipid parameter is the main objective to normalize?",
      "options": [
        "Total cholesterol",
        "Triglycerides",
        "LDL cholesterol",
        "HDL cholesterol"
      ],
      "correctAnswer": 3,
      "explanation": "The accumulation of LDL-Cholesterol is considered the most atherogenic dyslipidemia, which is why it is the main parameter to normalize."
    },
    {
      "question": "How many hours of fasting are suggested for lipid profile?",
      "options": [
        "less than six hours",
        "Ten to twelve hours",
        "Six to nine hours",
        "More than fourteen hours"
      ],
      "correctAnswer": 2,
      "explanation": "Recommendations for measuring total cholesterol, triglycerides and HDL-cholesterol suggest fasting for 9 to 12 hours."
    },
    {
      "question": "What type of xanthomas suggests familial hypercholesterolemia?",
      "options": [
        "Eruptive xanthomas",
        "Xanthomas palmaris",
        "Tuberous xanthomas",
        "Tendon xanthomas"
      ],
      "correctAnswer": 4,
      "explanation": "Tendon xanthomas, frequently located in the Achilles tendon or extensors of the hands, establish the diagnosis of familial hypercholesterolemia."
    },
    {
      "question": "What lipid is estimated with the Friedewald formula?",
      "options": [
        "Total cholesterol",
        "Non-HDL cholesterol",
        "VLDL cholesterol",
        "LDL cholesterol"
      ],
      "correctAnswer": 4,
      "explanation": "Elements of the lipid profile are used to estimate LDL cholesterol using the Friedewald formula."
    },
    {
      "question": "What pattern defines mixed dyslipidemia?",
      "options": [
        "CT < 200 and TG > 200",
        "CT > 200 and TG < 150",
        "CT < 200 and HDL < 40",
        "CT > 200 and TG > 150"
      ],
      "correctAnswer": 4,
      "explanation": "Mixed hyperlipidemia is defined by the presence of total cholesterol (TC) greater than 200 mg/dL and triglycerides (TG) greater than 150 mg/dL."
    },
    {
      "question": "What triglyceride value is related to the risk of pancreatitis?",
      "options": [
        "Greater than 150 mg/dL",
        "Greater than 500 mg/dL",
        "Greater than 200 mg/dL",
        "Greater than 1000 mg/dL"
      ],
      "correctAnswer": 4,
      "explanation": "Triglyceride levels above 1000 mg/dL are a common cause of pancreatitis and are associated with eruptive xanthomas."
    },
    {
      "question": "What is the common key element in metabolic syndrome?",
      "options": [
        "Chronic inflammation",
        "High blood pressure",
        "insulin resistance",
        "High blood glucose"
      ],
      "correctAnswer": 3,
      "explanation": "Insulin resistance was identified as the common and key element to explain the cardiovascular disease associated with metabolic syndrome."
    },
    {
      "question": "What is the BMI range for Grade I Obesity, according to Europe?",
      "options": [
        "Greater than 40.0",
        "Between 18.5 and 24.9",
        "Between 25.0 and 29.9",
        "Between 30.0 and 39.9"
      ],
      "correctAnswer": 3,
      "explanation": "The European consensus defines grade I obesity by a Body Mass Index (BMI) that is between 25 and 29.9."
    },
    {
      "question": "What percentage of SCORE risk is associated with 'Very High Risk'?",
      "options": [
        "Less than 1%",
        "Between 5% and 10%",
        "Greater than or equal to 10%",
        "Between 1% and 5%"
      ],
      "correctAnswer": 3,
      "explanation": "The Very High Risk group, in the European categories, is associated with a risk of fatal coronary heart disease (using SCORE) greater than or equal to 10%."
    },
    {
      "question": "What is the main action of metformin?",
      "options": [
        "Decreases liver glucose",
        "Increases cellular insulin",
        "Inhibits lipid absorption",
        "Decreases kidney blood glucose"
      ],
      "correctAnswer": 1,
      "explanation": "Metformin, a hypoglycemic medication, primarily decreases hepatic glucose production."
    },
    {
      "question": "What is stimulated in hyperinsulinemia through MAPK?",
      "options": [
        "eNOS expression",
        "Endothelin expression",
        "Nitric oxide synthesis",
        "Decrease in PAI-1"
      ],
      "correctAnswer": 2,
      "explanation": "Hyperinsulinemia stimulates endothelin expression through mitogenesis-activating protein kinase (MAPK)."
    },
    {
      "question": "Which carrier lipoprotein has the greatest atherogenic risk?",
      "options": [
        "Chylomicrons",
        "HDL cholesterol",
        "VLDL-1 cholesterol",
        "LDL cholesterol"
      ],
      "correctAnswer": 4,
      "explanation": "The accumulation of LDL (low-density lipoproteins) is considered one of the most atherogenic dyslipidemias."
    },
    {
      "question": "What physical sign establishes the diagnosis of familial hypercholesterolemia?",
      "options": [
        "corneal arch",
        "Eruptive xanthomas",
        "senile arch",
        "Tendon xanthomas"
      ],
      "correctAnswer": 4,
      "explanation": "Tendon xanthomas, which appear in the Achilles tendon or the extensors of the hands, establish the diagnosis of familial hypercholesterolemia."
    },
    {
      "question": "What is the goal of ApoB for very high risk patients?",
      "options": [
        "Less than 100 mg/dL",
        "Less than 120 mg/dL",
        "Less than 80 mg/dL",
        "Less than 70 mg/dL"
      ],
      "correctAnswer": 3,
      "explanation": "The European consensus proposes apolipoprotein B as a secondary therapeutic objective of less than 80 mg/dL for very high-risk cases."
    },
    {
      "question": "In what case are fibrates mainly used?",
      "options": [
        "high LDL",
        "Mild hypercholesterolemia",
        "normal HDL",
        "Very high triglycerides"
      ],
      "correctAnswer": 4,
      "explanation": "Fibrates are primarily used in people with triglyceride levels greater than 500 mg/dL, due to the risk of pancreatitis."
    },
    {
      "question": "What tool predicts cardiovascular risk in the Mexican population?",
      "options": [
        "NCEP",
        "Framingham",
        "SCORE",
        "Globorisk"
      ],
      "correctAnswer": 4,
      "explanation": "The Globorisk tool is recommended as an alternative to SCORE, since it was calibrated for the Mexican population."
    },
    {
      "question": "What feature is common in familial combined hyperlipidemia?",
      "options": [
        "Absence of xanthomas",
        "Very high LDL cholesterol",
        "High HDL values",
        "Stable lipid profile"
      ],
      "correctAnswer": 1,
      "explanation": "An important feature of familial combined hyperlipidemia is the absence of xanthomas."
    },
    {
      "question": "What HDL level defines hypoalphalipoproteinemia?",
      "options": [
        "HDL < 40 mg/dL",
        "HDL > 60 mg/dL",
        "HDL between 40 and 60",
        "HDL > 90 mg/dL"
      ],
      "correctAnswer": 1,
      "explanation": "Hypoalphalipoproteinemia is defined by an HDL cholesterol concentration less than 40 mg/dL."
    },
    {
      "question": "What is an important effect of glitazones on body fat?",
      "options": [
        "They redistribute fat",
        "Increase lipotoxicity",
        "They inhibit adipocytes",
        "They block PPAR receptors"
      ],
      "correctAnswer": 1,
      "explanation": "Glitazones stimulate the proliferation of adipocytes, which causes the redistribution of fat from the visceral space to the subcutaneous tissue, thus reducing lipotoxicity in other tissues."
    },
    {
      "question": "What is the most frequent adverse event due to glitazones?",
      "options": [
        "severe diarrhea",
        "Low glucose",
        "abdominal pain",
        "Increase in body weight"
      ],
      "correctAnswer": 4,
      "explanation": "An adverse event frequently associated with the use of glitazones, despite the improvement in insulin sensitivity, is weight gain in patients."
    },
    {
      "question": "What intestinal hormones are released after eating food?",
      "options": [
        "Somatostatin",
        "Catecholamines",
        "C Peptides",
        "Incretins"
      ],
      "correctAnswer": 4,
      "explanation": "Incretins are a series of hormones that are produced and secreted in the intestine in direct response to food ingestion."
    },
    {
      "question": "What enzyme rapidly deactivates the GLP-1 peptide?",
      "options": [
        "Dipeptidylpeptidase IV",
        "Phospholipase",
        "Serine protease",
        "Glucagon kinase"
      ],
      "correctAnswer": 1,
      "explanation": "The enzyme dipeptidylpeptidase IV (DPPIV) is responsible for degrading GLP-1, giving it a short half-life. Inhibitors of this enzyme increase the half-life of endogenous incretins."
    },
    {
      "question": "Which of these drugs belongs to angiotensin II blockers?",
      "options": [
        "Valsartan",
        "Lisinopril",
        "Amlodipine",
        "Propranolol"
      ],
      "correctAnswer": 1,
      "explanation": "Valsartan (together with losartan, irbesartan, etc.) is an angiotensin II receptor blocker (ARB), which acts on AT1 receptors."
    },
    {
      "question": "What is the main advantage of ARBs over ACEIs?",
      "options": [
        "Lower cost",
        "Greater power",
        "They are for pregnant women",
        "They do not cause dry cough"
      ],
      "correctAnswer": 4,
      "explanation": "A key difference is that angiotensin II blockers can be used in patients who develop a dry cough, a common side effect of angiotensin-converting enzyme (ACE) inhibitors."
    },
    {
      "question": "What component of MS dyslipidemia do fibrates treat?",
      "options": [
        "HDL cholesterol",
        "elevated LDL",
        "Hypertriglyceridemia",
        "Hypercholesterolemia"
      ],
      "correctAnswer": 3,
      "explanation": "Fibric acid derivatives (fibrates) are especially useful for the treatment of hypertriglyceridemia, one of the components of the dyslipidemic triad of metabolic syndrome."
    },
    {
      "question": "Which enzyme is inhibited by statins?",
      "options": [
        "Adenylate cyclase",
        "Protein kinase C",
        "DPPIV",
        "HMG-CoA reductase"
      ],
      "correctAnswer": 4,
      "explanation": "Statins are drugs that act as HMG-CoA reductase inhibitors and are used to treat hypercholesterolemia."
    },
    {
      "question": "What does the correlation described by Barker predict?",
      "options": [
        "Adult coronary heart disease risk",
        "Short adult stature",
        "Neonatal insulin resistance",
        "Obesity in childhood"
      ],
      "correctAnswer": 1,
      "explanation": "Barker described the correlation between low birth weight and an increased risk of coronary heart disease in adulthood."
    },
    {
      "question": "What condition increases the risk of adult metabolic disorders?",
      "options": [
        "premature birth",
        "high birth weight",
        "Low birth weight",
        "Neonatal infections"
      ],
      "correctAnswer": 3,
      "explanation": "Children born with low weight have a greater predisposition to develop metabolic conditions, such as insulin resistance, in adulthood."
    },
    {
      "question": "What is a good predictor of metabolic risk in children?",
      "options": [
        "BMI at birth",
        "head circumference",
        "Waist to size ratio",
        "Glucose concentration"
      ],
      "correctAnswer": 3,
      "explanation": "The waist/height ratio has been shown to be a good predictor of metabolic risk in the pediatric population, since it is associated with central obesity."
    },
    {
      "question": "What is the main pathophysiological factor in NAFLD?",
      "options": [
        "Glucotoxicity",
        "Oxidative stress",
        "Liver dysfunction",
        "insulin resistance"
      ],
      "correctAnswer": 4,
      "explanation": "Insulin resistance is the primary pathophysiological mechanism of nonalcoholic fatty liver disease (NAFLD), linked to hepatic fat accumulation (steatosis)."
    },
    {
      "question": "What is the main function of insulin in metabolism?",
      "options": [
        "Anabolic",
        "Catabolic",
        "Proinflammatory",
        "Neurotransmitter"
      ],
      "correctAnswer": 1,
      "explanation": "Insulin is a hormone with outstanding anabolic functions in the metabolism of carbohydrates, lipids and proteins."
    },
    {
      "question": "What event triggers insulin secretion from glucose?",
      "options": [
        "Closure of K+ ATP channels",
        "PKA activation",
        "Increased glucagon",
        "Opening of Cl- channels"
      ],
      "correctAnswer": 1,
      "explanation": "The increase in intracellular ATP (due to glucose metabolism) promotes the closure of ATP-sensitive potassium channels (K+ATP), which depolarizes the cell and initiates the insulin secretion cascade."
    },
    {
      "question": "What type of cell produces pancreatic polypeptide?",
      "options": [
        "Alpha cells",
        "beta cells",
        "epsilon cells",
        "PP cells"
      ],
      "correctAnswer": 4,
      "explanation": "Pancreatic polypeptide (PP) is one of the hormones produced by the endocrine pancreas, and is secreted specifically by the PP cells of the pancreatic islets."
    },
    {
      "question": "What molecules increase insulin release in the first phase?",
      "options": [
        "Cortisol and ACTH",
        "Thyroid hormones",
        "VIP and GLP-1",
        "Insulin and Glucagon"
      ],
      "correctAnswer": 3,
      "explanation": "Gut hormones such as vasoactive intestinal peptide (VIP) and glucagon-like peptide 1 (GLP-1) activate PKA in the beta cell, potentiating first-phase insulin release more than glucose stimulation alone."
    },
    {
      "question": "What percentage of diabetes cases corresponds to type 2?",
      "options": [
        "less than fifty",
        "Between ninety and ninety-five",
        "sixty to seventy",
        "Eighty to eighty-five"
      ],
      "correctAnswer": 2,
      "explanation": "Type 2 diabetes mellitus (T2DM) is the most common form, accounting for between 90% and 95% of all diabetes cases."
    },
    {
      "question": "What is the main cause of death per year in Mexico?",
      "options": [
        "Diabetes Mellitus",
        "breast cancer",
        "infectious diseases",
        "traffic accidents"
      ],
      "correctAnswer": 1,
      "explanation": "In Mexico, Diabetes Mellitus occupies first place in the number of deaths per year, showing an increasing trend in mortality rates."
    },
    {
      "question": "What is the risk of DM2 with only one affected parent?",
      "options": [
        "40 percent risk",
        "Risk less than 10 percent",
        "70 percent risk",
        "20 percent risk"
      ],
      "correctAnswer": 1,
      "explanation": "The lifetime risk of developing Type 2 Diabetes Mellitus is 40% for subjects who have only one parent affected by the disease."
    },
    {
      "question": "What concept explains why glucose induces long-term changes?",
      "options": [
        "Metabolic memory",
        "Saving hypothesis",
        "latent autoimmunity",
        "Systemic lipotoxicity"
      ],
      "correctAnswer": 1,
      "explanation": "The 'metabolic memory' hypothesis suggests that elevated glucose can induce histone modifications in endothelial cells, which can then be stored long-term and predispose to diabetes complications."
    },
    {
      "question": "Which glucose transporter is insulin dependent?",
      "options": [
        "GLUT-1 in the barrier.",
        "GLUT-3 in the brain.",
        "GLUT-4 in muscle and fat.",
        "GLUT-2 in beta cells."
      ],
      "correctAnswer": 3,
      "explanation": "Glucose transporter type 4 (GLUT-4) is found in muscle and adipose tissue. Insulin is necessary for its translocation to the cell membrane, allowing glucose to enter the cell."
    },
    {
      "question": "What is the main mechanism of action of metformin?",
      "options": [
        "Stimulate insulin secretion.",
        "Block intestinal absorption.",
        "Increase liver glucose.",
        "Decrease liver production."
      ],
      "correctAnswer": 4,
      "explanation": "The primary mechanism of action of metformin is to decrease hepatic glucose production by reducing gluconeogenesis. It also increases glucose utilization in peripheral tissues."
    },
    {
      "question": "What is the main net effect of insulin?",
      "options": [
        "Promote ketogenesis.",
        "Increase blood glucose.",
        "Promote cellular anabolism.",
        "Inhibit protein synthesis."
      ],
      "correctAnswer": 3,
      "explanation": "Insulin is considered the anabolic hormone par excellence, since it promotes the synthesis of glycogen and proteins, and inhibits lipolysis and gluconeogenesis. Its final effect is the reduction of blood glucose."
    },
    {
      "question": "What is the main incretin responsible for its effect?",
      "options": [
        "Glucagon.",
        "Vasoactive intestinal peptide.",
        "Insulinotropic glucose peptide.",
        "Glucagon-like polypeptide 1."
      ],
      "correctAnswer": 4,
      "explanation": "Incretins are intestinal hormones (GLP-1 and GIP) that enhance insulin secretion. Of these, Glucagon-like Peptide type 1 (GLP-1) is responsible for almost all of the incretin effect."
    },
    {
      "question": "How long does the early phase of insulin secretion last?",
      "options": [
        "Less than ten minutes.",
        "About fifteen minutes.",
        "More than thirty minutes.",
        "Lasts up to an hour."
      ],
      "correctAnswer": 1,
      "explanation": "Insulin secretion in response to an intravenous glucose load has an early phase (Phase 1) that begins 1 minute after the bolus, reaches a rapid peak, and lasts about 10 minutes."
    },
    {
      "question": "How many subunits does the insulin receptor consist of?",
      "options": [
        "Two alpha chains and one beta.",
        "Four beta subunits.",
        "Two alpha and two beta subunits.",
        "Four tyrosine chains."
      ],
      "correctAnswer": 3,
      "explanation": "The insulin receptor is a tetrameric protein made up of two extracellular alpha (α) subunits and two transmembrane and intracellular beta (β) subunits, linked by disulfide bridges."
    },
    {
      "question": "What signaling pathway mediates insulin-promoted growth?",
      "options": [
        "Phosphatidyl inositol 3 kinase.",
        "Akt protein kinase pathway.",
        "Glycogen synthetase pathway.",
        "Mitogen-activated kinase."
      ],
      "correctAnswer": 4,
      "explanation": "The Mitogen Activated Kinase (MAP) pathway is responsible for insulin-promoted growth through gene induction, while the PI3-K pathway mediates the metabolic response."
    },
    {
      "question": "What is the most powerful counterregulatory hormone?",
      "options": [
        "Catecholamines.",
        "Growth hormone.",
        "Glucagon.",
        "Somatostatin."
      ],
      "correctAnswer": 3,
      "explanation": "Glucagon, secreted by the alpha cells of the pancreas, is the most potent counterregulatory hormone, stimulating hepatic glycogenolysis and gluconeogenesis."
    },
    {
      "question": "How does cortisol exert its counterregulatory effect?",
      "options": [
        "Decreases liver production.",
        "Inhibits lipolysis.",
        "Promotes peripheral uptake.",
        "Increases hepatic gluconeogenesis."
      ],
      "correctAnswer": 4,
      "explanation": "Cortisol increases hepatic glucose production by increasing gluconeogenesis, and decreases the action of insulin in peripheral tissues (insulin resistance)."
    },
    {
      "question": "What percentage of glucose does the kidney produce when fasting?",
      "options": [
        "Less than ten percent.",
        "About fifty percent.",
        "Twenty-five percent postabsorptive.",
        "Almost one hundred percent total."
      ],
      "correctAnswer": 3,
      "explanation": "The kidney is an important regulator of glucose homeostasis, participating in gluconeogenesis and assuming 25% of glucose production at the post-absorptive level."
    },
    {
      "question": "What renal transporter reabsorbs ninety percent?",
      "options": [
        "High affinity SGLT-1.",
        "GLUT-4 dependent.",
        "GLUT-1 in all tissues.",
        "Low affinity SGLT-2."
      ],
      "correctAnswer": 4,
      "explanation": "SGLT2 (sodium-coupled glucose transporter type 2) has low affinity, but high transport capacity and is responsible for 90% of the reabsorption of filtered glucose in the proximal tubule."
    },
    {
      "question": "When does plasma glucose exceed the glycosuria threshold?",
      "options": [
        "When it is 120 milligrams per deciliter.",
        "When exceeding 220 milligrams per minute.",
        "Less than 180 grams per day.",
        "In total renal reabsorption."
      ],
      "correctAnswer": 2,
      "explanation": "Glycosuria appears when the glucose load in the tubule exceeds 220 mg/min, which saturates the maximum reabsorption capacity of the SGLT transporters."
    },
    {
      "question": "What is the pathophysiological substrate of type 1 diabetes?",
      "options": [
        "Resistance to insulin action.",
        "Autoimmune destruction of beta cells.",
        "Progressive secretion defect.",
        "Failure in the incretin effect."
      ],
      "correctAnswer": 2,
      "explanation": "Type 1 Diabetes Mellitus (DM1) is due to a specific autoimmune process that results in the destruction of the beta cells of the pancreas and the consequent lack of insulin."
    },
    {
      "question": "What predominates in the pathophysiology of type 2 diabetes?",
      "options": [
        "Total autoimmune destruction.",
        "Insulin gene mutation.",
        "Rapid destruction of alpha cells.",
        "Resistance to insulin action."
      ],
      "correctAnswer": 4,
      "explanation": "In Type 2 Diabetes Mellitus (DM2) what predominates is resistance to the action of insulin, to which is added a progressive defect in insulin secretion."
    },
    {
      "question": "What is the overall glycated hemoglobin (HbA1c) goal?",
      "options": [
        "Less than 8.5 percent.",
        "Equal or less than 7.0 percent.",
        "Greater than 6.5 percent.",
        "From 9.0 to 10.0 percent."
      ],
      "correctAnswer": 2,
      "explanation": "The control goal for most patients is an HbA1c of 7.0% or lower, although it should be individualized to 6.5% for selected patients or 8.0% in cases at risk of hypoglycemia."
    },
    {
      "question": "What complication does intensive treatment reduce in DM1?",
      "options": [
        "Severe hyperglycemia.",
        "Development of retinopathy.",
        "Morbid obesity.",
        "Pancreatic cancer."
      ],
      "correctAnswer": 2,
      "explanation": "Intensive treatment in DM1 (multiple doses of insulin or infusion pump) demonstrated a significant reduction in the risk of development and progression of microvascular complications, such as retinopathy."
    },
    {
      "question": "How prevalent is gestational diabetes in Mexico?",
      "options": [
        "Between 6 and 11 percent.",
        "About 50 percent.",
        "Less than 2 percent.",
        "Greater than 90 percent."
      ],
      "correctAnswer": 1,
      "explanation": "While in industrialized countries the prevalence is 2%, in Mexico a frequency of Gestational Diabetes Mellitus (GDM) is estimated to be between 6 to 11% of all pregnancies."
    },
    {
      "question": "What is the first insulin strategy in uncontrolled DM2?",
      "options": [
        "Start intensive basal bolus.",
        "Nighttime dose of intermediate insulin.",
        "Insulin infusion pump.",
        "Rapid preprandial insulin."
      ],
      "correctAnswer": 2,
      "explanation": "For patients with DM2 in whom control is not achieved with oral hypoglycemic agents, it is recommended to initially add a nocturnal dose of intermediate insulin, without suspending oral drugs."
    },
    {
      "question": "What is the 2-hour postprandial blood glucose goal?",
      "options": [
        "From 80 to 130 milligrams per deciliter.",
        "Between 140 to 180 milligrams per deciliter.",
        "Maximum of 200 milligrams per deciliter.",
        "Less than 70 milligrams per deciliter."
      ],
      "correctAnswer": 2,
      "explanation": "One of the goals of glycemic control is to achieve a blood glucose level two hours after eating (postprandial) between 140 and 180 mg/dL. Fasting blood glucose is 80 to 130 mg/dL."
    },
    {
      "question": "How is tumor necrosis factor alpha (TNFα) related to resistance?",
      "options": [
        "Neutralizes phosphorylation.",
        "Decreases leptin.",
        "Increases glucose transport.",
        "Reduces receptor autophosphorylation."
      ],
      "correctAnswer": 4,
      "explanation": "TNFα increases serine phosphorylation of insulin receptor substrates (IRS), which inhibits their autophosphorylation capacity and receptor tyrosine kinase activity, causing insulin resistance."
    }
  ]
}